About this trial
GBM patients receiving PDT treatment (50 cases,surgery combined with photodynamic therapy) and traditional treatment (50 cases,traditional surgery) in our hospital and partner hospitals were collected. The prognosis was analyzed by comparing with the control group from multiple perspectives such as image evaluation, imaging effect, Karnofsky score, median survival time and survival rate.
Eligibility criteria
Qualifiers
None
Disqualifiers
Photosensitizer allergy.
Severe coagulation disorder.
Patients with severe cardiovascular and cerebrovascular diseases, especially patients in the acute stage.
Multiple organ failure, end-stage patients. ⑤ Pregnant women: Photofrin is considered a class C pregnancy risk (toxic, non-teratogenic) drug with non-dialysis properties.
Trial design
Treatments tested in this trial
- Photodynamic therapy (PDT)
- GBM patients recevied traditional treatment options
Treatment groups
Sponsors and collaborators
Zhejiang Provincial People's Hospital
Lead sponsor
The Second Affiliated Hospital of Harbin Medical University
Collaborator